Cargando…

PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents

BACKGROUND: Between 2012 and 2015, the PRALIMAP-INES trial was carried-out in the France including 1143 adolescents aged 13-18 years old and aimed at reducing weight social inequalities in adolescence. The main result showed that a proportionate universalism principle is an effective way to reduce w...

Descripción completa

Detalles Bibliográficos
Autores principales: Omorou, A, Mannneville, F, Langlois, J, Böhme, P, Beguinet, M, Dosda, A, Briançon, S, Legrand, K, Lecomte, E, Spitz, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595245/
http://dx.doi.org/10.1093/eurpub/ckad160.1420
_version_ 1785124823752507392
author Omorou, A
Mannneville, F
Langlois, J
Böhme, P
Beguinet, M
Dosda, A
Briançon, S
Legrand, K
Lecomte, E
Spitz, E
author_facet Omorou, A
Mannneville, F
Langlois, J
Böhme, P
Beguinet, M
Dosda, A
Briançon, S
Legrand, K
Lecomte, E
Spitz, E
author_sort Omorou, A
collection PubMed
description BACKGROUND: Between 2012 and 2015, the PRALIMAP-INES trial was carried-out in the France including 1143 adolescents aged 13-18 years old and aimed at reducing weight social inequalities in adolescence. The main result showed that a proportionate universalism principle is an effective way to reduce weight social inequalities in adolescence. About 10 years later, the PRALIMAP-Cineco study aims to investigate the social, economic, educational and health trajectories among PRALIMAP-INES participants. METHODS: Young adults are contacted by clinical research team and invited to participate to the follow-up. If they agree, they are asked to complete a self-reported questionnaire (sociodemographic, diet, tobacco, alcohol, physical activity, sedentary behaviour, quality of life) and then invited to realise a medical visit for global check-up including weight measures. RESULTS: Inclusion is currently in progress and 248 participants are contacted (Male: 130, 52.4%). The mean BMI is 28.5±5.4 kg/m(2), 40% of overweight and 30.7% obesity. Among overweight/obese adolescents, 80.1% remain overweight/obese (50.5% of overweight adolescents remain overweight while 67.6% of obese remain obese in adulthood) and 19.9% switch to normal weight in adulthood. No significant difference is observed between advantaged with standard intervention (81.3%) and less advantaged with strengthened intervention (80.7%) groups. CONCLUSIONS: Post-intervention follow-up suggest that overweight/obesity in adolescence is strongly predictive of overweight/obesity in adulthood without differential trajectories according to socioeconomic status. It would be very interesting to investigate the profile of overweight adolescents who switch to normal to understand the determinants of this favourable trajectory. KEY MESSAGES: • Adolescents with overweight or obesity are more likely to be overweight or obese in adulthood confirming the need of early age public health prevention programmes. • Lifelong prevention is also necessary to ensure more effective public policy.
format Online
Article
Text
id pubmed-10595245
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105952452023-10-25 PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents Omorou, A Mannneville, F Langlois, J Böhme, P Beguinet, M Dosda, A Briançon, S Legrand, K Lecomte, E Spitz, E Eur J Public Health Poster Displays BACKGROUND: Between 2012 and 2015, the PRALIMAP-INES trial was carried-out in the France including 1143 adolescents aged 13-18 years old and aimed at reducing weight social inequalities in adolescence. The main result showed that a proportionate universalism principle is an effective way to reduce weight social inequalities in adolescence. About 10 years later, the PRALIMAP-Cineco study aims to investigate the social, economic, educational and health trajectories among PRALIMAP-INES participants. METHODS: Young adults are contacted by clinical research team and invited to participate to the follow-up. If they agree, they are asked to complete a self-reported questionnaire (sociodemographic, diet, tobacco, alcohol, physical activity, sedentary behaviour, quality of life) and then invited to realise a medical visit for global check-up including weight measures. RESULTS: Inclusion is currently in progress and 248 participants are contacted (Male: 130, 52.4%). The mean BMI is 28.5±5.4 kg/m(2), 40% of overweight and 30.7% obesity. Among overweight/obese adolescents, 80.1% remain overweight/obese (50.5% of overweight adolescents remain overweight while 67.6% of obese remain obese in adulthood) and 19.9% switch to normal weight in adulthood. No significant difference is observed between advantaged with standard intervention (81.3%) and less advantaged with strengthened intervention (80.7%) groups. CONCLUSIONS: Post-intervention follow-up suggest that overweight/obesity in adolescence is strongly predictive of overweight/obesity in adulthood without differential trajectories according to socioeconomic status. It would be very interesting to investigate the profile of overweight adolescents who switch to normal to understand the determinants of this favourable trajectory. KEY MESSAGES: • Adolescents with overweight or obesity are more likely to be overweight or obese in adulthood confirming the need of early age public health prevention programmes. • Lifelong prevention is also necessary to ensure more effective public policy. Oxford University Press 2023-10-24 /pmc/articles/PMC10595245/ http://dx.doi.org/10.1093/eurpub/ckad160.1420 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Displays
Omorou, A
Mannneville, F
Langlois, J
Böhme, P
Beguinet, M
Dosda, A
Briançon, S
Legrand, K
Lecomte, E
Spitz, E
PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents
title PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents
title_full PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents
title_fullStr PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents
title_full_unstemmed PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents
title_short PRALIMAP-CINECO Cohort: 10-year post-intervention weight trajectories of PRALIMAP-INES adolescents
title_sort pralimap-cineco cohort: 10-year post-intervention weight trajectories of pralimap-ines adolescents
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595245/
http://dx.doi.org/10.1093/eurpub/ckad160.1420
work_keys_str_mv AT omoroua pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT mannnevillef pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT langloisj pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT bohmep pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT beguinetm pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT dosdaa pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT briancons pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT legrandk pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT lecomtee pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents
AT spitze pralimapcinecocohort10yearpostinterventionweighttrajectoriesofpralimapinesadolescents